Breast Cancer SABCS 2016: Menopausal symptoms may be mistaken for tamoxifen side effects December 12, 2016 Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug…
Breast Cancer SABCS 2016: Scalp-cooling system reduced hair loss in many breast cancer patients receiving chemotherapy December 12, 2016 A system designed to prevent hair loss in chemotherapy patients by cooling the scalp was…
Commentary NSW adults risk dying of embarrassment December 12, 2016 Over a third of adults in NSW think bowel cancer is ‘dirty and embarrassing’, potentially…
Editor's Choice Prostate cancer patients more likely to die of other diseases, say 15-year PLCO results December 12, 2016 Starting in 1993 and ending in 2001, ten academic medical centers in the United States…
Commentary Diet, the gut microbiome and colorectal cancer: are they linked? December 12, 2016 Recent evidence from animal models suggests a role for specific types of intestinal bacteria in…
Breast Cancer Breast cancer patients could benefit from controversial hormone December 12, 2016 An international team of researchers involving the University of Adelaide is tackling the controversy over…
Breast Cancer SABCS 2016: Depression drug reduces joint pain for women with early stage breast cancer December 11, 2016 A drug typically used to treat depression and anxiety can significantly reduce joint pain in…
Breast Cancer SABCS 2016: Extended letrozole therapy showed limited benefit in postmenopausal women with early-stage, HR-positive breast cancer December 11, 2016 Five additional years of hormone therapy with letrozole following an initial five years of aromatase…
Breast Cancer Fat intake shows link to metastasis December 11, 2016 The discovery of metastasis-promoting protein receptors (CD36) in mouse cells has led to the launch…
Breast Cancer SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive breast cancer December 10, 2016 Progression-free survival was more than doubled for patients with metastatic hormone receptor (HR)-positive, HER2-negative breast…